Влезте в профила си за пълен достъп до възможностите на Eclipse.
Вход
Каталог "Библиографии"
| Списание
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
Gisslinger, H., Georgiev, P., al., e. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study,
, .
Gisslinger, H., Georgiev, P., al., e. .
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
: , .
Gisslinger, H., Georgiev, P., al., e. ()
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study,
:
Gisslinger, H.,
Georgiev, P., &
al., e.
().
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study. The Lancet Haematology; The Lancet Haematology.